BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
CLSA maintains sell on Ipca Labs
CLSA has maintained 'sell' on Ipca Laboratories for target price of Rs 661/share. It says valuations reflect strong recovery in earnings and sees operating leverage benefits in FY'17-18. CLSA adds that IPCA's peak valuation is 18 times 1-year forward price-to-earning and it expects flat revenue with pressure on profitability in FY'16.